CORRECTING and REPLACING GRAPHIC Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive...
LOS ANGELES--(BUSINESS WIRE)--Jun 3, 2019-- |!| Oelwein
LOS ANGELES--(BUSINESS WIRE)--Jun 3, 2019-- |!| Oelwein